Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | INF2 |
| Upstream (Parents) |
|---|
| (<<) AKT1 → INF2 |
| (<<) ARHGAP10 → INF2 |
| (<<) ARSI → INF2 |
| (<<) ATP2B4 → INF2 |
| (<<) BCL6 → INF2 |
| (<<) CREBBP → INF2 |
| (<<) CSF2 → INF2 |
| (<<) E2F7 → INF2 |
| (<<) FLJ35934 → INF2 |
| (<<) FOXO3 → INF2 |
| (<<) GULP1 → INF2 |
| (<<) MMP15 → INF2 |
| (<<) MMP28 → INF2 |
| (<<) NDST1 → INF2 |
| (<<) PFDN1 → INF2 |
| (<<) PIK3CA → INF2 |
| (<<) PKIG → INF2 |
| (<<) PROCR → INF2 |
| (<<) RAD51L3 → INF2 |
| (<<) RFFL → INF2 |
| (<<) SGSH → INF2 |
| (<<) TAGLN2 → INF2 |
| (<<) UBE2D4 → INF2 |
| (<<) VEGFC → INF2 |
| Downstream (Children) |
|---|
| INF2 → IL1RN (>>) |
| INF2 → STAM2 (>>) |
| INF2 → TYRO3 (>>) |
